ResearchHub Logo
Currency
Display format
RSCUSD

Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial

Authors
Pratima ChowdaryStefan LethagenPantep Angchaisuksiri
Journal
Journal of Thrombosis and Haemostasis
Published
January 31, 2015
Sign in to comment
Add a comment...

No comments yet. Start the conversation!

Your contribution could help open science.

Supporters

Support the authors with ResearchCoin

Topics

DOI

10.1111/jth.12864

License

Unknown License

Other Formats

Safety and pharmacokinetics of anti‐TFPI antibody (conciz... | ResearchHub